Related references
Note: Only part of the references are listed.Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer
Ingeborg E. de Kruijff et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
Aristomenis Anestis et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Consideration of breast cancer subtype in targeting the androgen receptor
Clasina M. Venema et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
Giuseppe Bronte et al.
BMC CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
AR Expression in Breast Cancer CTCs Associates with Bone Metastases
Nicola Aceto et al.
MOLECULAR CANCER RESEARCH (2018)
Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
Kristine Astvatsaturyan et al.
PLOS ONE (2018)
The prognostic value of androgen receptors in breast cancer subtypes
Maria Ryssdal Kraby et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
Bram De laere et al.
EUROPEAN UROLOGY (2017)
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy
Sara Ravaioli et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2017)
Molecular classification of breast cancer: what the pathologist needs to know
Emad A. Rakha et al.
PATHOLOGY (2017)
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
V. Conteduca et al.
ANNALS OF ONCOLOGY (2017)
Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
Aristomenis Anestis et al.
CANCER TREATMENT REVIEWS (2015)
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort
Karin Elebro et al.
CLINICAL CANCER RESEARCH (2015)
PD-L1 is highly expressed in Enzalutamide resistant prostate cancer
Jennifer L. Bishop et al.
ONCOTARGET (2015)
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast
Maria Maddalena Tumedei et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2015)
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
Francisco E. Vera-Badillo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer
Aye Aye Thike et al.
MODERN PATHOLOGY (2014)
Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
Ramesh Narayanan et al.
PLOS ONE (2014)
Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer
Christopher C. Coss et al.
STEROIDS (2014)
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R. Cochrane et al.
BREAST CANCER RESEARCH (2014)
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Hiroko Masuda et al.
CLINICAL CANCER RESEARCH (2013)
Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model
Andressa Ardiani et al.
CLINICAL CANCER RESEARCH (2013)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity
Francini de Mattos Lima Lin et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Research Resource: Interplay between the Genomic and Transcriptional Networks of Androgen Receptor and Estrogen Receptor α in Luminal Breast Cancer Cells
Eleanor F. Need et al.
MOLECULAR ENDOCRINOLOGY (2012)
The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
T. E. Hickey et al.
MOLECULAR ENDOCRINOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
S. Park et al.
ANNALS OF ONCOLOGY (2011)
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
Sibylle Loibl et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni et al.
CANCER CELL (2011)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Laura C. Collins et al.
MODERN PATHOLOGY (2011)
Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models
K. A. Walters et al.
HUMAN REPRODUCTION UPDATE (2010)
Roles of Androgen Receptor in Male and Female Reproduction: Lessons From Global and Cell-Specific Androgen Receptor Knockout (ARKO) Mice
Xinchang Zhou
JOURNAL OF ANDROLOGY (2010)
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
The Role of Androgens in Normal and Malignant Breast Tissue
Katharina Tiefenbacher et al.
BREAST CARE (2008)
Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor
SY Yeh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A physiologic role for testosterone in limiting estrogenic stimulation of the breast
C Dimitrakakis et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2003)
Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression
J Zhou et al.
FASEB JOURNAL (2000)
Share Paper
